| Net Cash Provided by (Used in) Operating Activities |
$57,063 |
USD |
|
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$5,469 |
USD |
|
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$37,000 |
USD |
|
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
58,608,825 |
shares |
0.34% |
Q2 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$65,078 |
USD |
2880% |
Q2 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$258,000 |
USD |
1.6% |
Q3 2024 |
FY 2024 |
| Depreciation |
$55,616 |
USD |
|
Q2 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$25,564,112 |
USD |
|
Q2 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$258,000 |
USD |
1.6% |
Q3 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
2,000,000 |
shares |
|
Q2 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Additional Paid in Capital |
$47,837,990 |
USD |
377% |
Q2 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
2,000,000 |
shares |
|
Q2 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2024 |
FY 2024 |
| Interest Expense |
$0 |
USD |
-100% |
Q2 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q3 2025 |